GINKGO BILOBA FOR IMPROVEMENT OF MEMORY AND QUALITY OF LIFE IN MULTIPLE SCLEROSIS: AN OPEN TRIAL

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

NOROOZIAN M.; MOHEBBI RASA S.; TASVIECHI A.K.; SAHRAIAN M.A.; KARAMGHADIRI N.; AKHONDZADEH S.

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Journal of Medicinal Plants Year:2011 | Volume:10 | Issue:39 Page(s): 33-42

Download Full-Text

View:

297

Download:

Cites:

Information Journal Paper

Title

GINKGO BILOBA FOR IMPROVEMENT OF MEMORY AND QUALITY OF LIFE IN MULTIPLE SCLEROSIS: AN OPEN TRIAL

Author(s)

Keywords

GINKGO BILOBA

MULTIPLE SCLEROSIS

MEMORY IMPAIRMENT

WECHSLER TEST

Abstract

Background: MULTIPLE SCLEROSIS (MS) is a chronic demyelinating disease that can affect cognitive function. The purpose of this study was to assess the efficacy of GINKGO BILOBA (GB) on improvement of MEMORY IMPAIRMENT and quality of life in patients with MS.Methods: This study was an 8-week, open study of patients with MS. Thirty patients was recruited from a variety of outpatient settings. All participants met McDonald's diagnostic criteria for MS and had Wechsler score of<80. All subjects received Ginkgo 240 mg/day, TDS except one that received 120 mg/day, TDS due to history of gastritis Participants were assessed by Wechsler memory scale, MSIS-29 test and Beck Depression Inventory (BDI) which measure memory, quality of life and depression respectively at baseline and after 8 weeks of treatment.Results: Administration of Ginkgo significantly improved Wechsler and MSIS-29 scores.Subjects who were less impaired at baseline on the WECHSLER TEST experienced more improvement with GB.Conclusion: The present study indicates GINKGO BILOBA as a very well tolerated medication for improvement of cognitive impairments in people suffering from MS.

Cites

No record.

References

Cite

APA: Copy

NOROOZIAN, M., MOHEBBI RASA, S., TASVIECHI, A.K., SAHRAIAN, M.A., KARAMGHADIRI, N., & AKHONDZADEH, S.. (2011). GINKGO BILOBA FOR IMPROVEMENT OF MEMORY AND QUALITY OF LIFE IN MULTIPLE SCLEROSIS: AN OPEN TRIAL. JOURNAL OF MEDICINAL PLANTS, 10(39), 33-42. SID. https://sid.ir/paper/578887/en

Vancouver: Copy

NOROOZIAN M., MOHEBBI RASA S., TASVIECHI A.K., SAHRAIAN M.A., KARAMGHADIRI N., AKHONDZADEH S.. GINKGO BILOBA FOR IMPROVEMENT OF MEMORY AND QUALITY OF LIFE IN MULTIPLE SCLEROSIS: AN OPEN TRIAL. JOURNAL OF MEDICINAL PLANTS[Internet]. 2011;10(39):33-42. Available from: https://sid.ir/paper/578887/en

IEEE: Copy

M. NOROOZIAN, S. MOHEBBI RASA, A.K. TASVIECHI, M.A. SAHRAIAN, N. KARAMGHADIRI, and S. AKHONDZADEH, “GINKGO BILOBA FOR IMPROVEMENT OF MEMORY AND QUALITY OF LIFE IN MULTIPLE SCLEROSIS: AN OPEN TRIAL,” JOURNAL OF MEDICINAL PLANTS, vol. 10, no. 39, pp. 33–42, 2011, [Online]. Available: https://sid.ir/paper/578887/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops